Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Mol Biol (Noisy-le-grand) ; 67(5): 6-15, 2022 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-35818277

RESUMEN

The current work was performed to explore the pharmacological mechanisms involved in the management of asthma and hypertension along with the safety profile of the Ceratonia siliqua (C. siliqua/Carob) pods. The bronchorelaxant, vasorelaxant, and cardioselective activities of C. siliqua pods were investigated using isolated rabbit tracheal, aortic, and paired atrial fragments on the Power lab data acquisition system. Normotensive rats were used to study antihypertensive activity. The plant extract and its fractions relaxed the carbachol-induced contraction in the tracheal fragments and shifted the concentration-response curve of carbachol towards the right confirming the muscarinic receptor antagonist activity. The relaxation of phenylephrine-induced contraction in an aortic fragment by the extract showed α- adrenergic blocking activity. Furthermore, the extract produced a cardio-selective response in the paired atria and decreased the blood pressure in anesthetized normotensive rats. The plant extract proved to be non-toxic in oral acute and chronic toxicity studies and did not demonstrate any sign of histopathological lesions. These results suggested that the plant extract was non-toxic and could be used in the management of lifetime therapies of respiratory and cardiovascular disorders without any unwanted effects.


Asunto(s)
Asma , Fabaceae , Hipertensión , Extractos Vegetales , Animales , Asma/tratamiento farmacológico , Carbacol , Fabaceae/química , Hipertensión/tratamiento farmacológico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Conejos , Ratas
2.
Artículo en Inglés | MEDLINE | ID: mdl-35579124

RESUMEN

BACKGROUND: The plant Berberis aristata is traditionally used and scientifically validated for treating obesity and hyperlipidemia. It is also traditionally used to treat gynecological abnormalities. Therefore, the present study was designed to evaluate the therapeutic potential of Berberis aristata for obesity-related reproductive changes and chemically characterize it. METHODS: High-fat diet was given to 36 female rats for six weeks to induce obesity and infertility. These obese rats were treated with 10 mg/kg orlistat or the plant extract at 125-500 mg/kg for 45 days. RESULTS: The GC-MS analysis of the plant extract included fructose, thymic acid and other hydrocarbons. The plant extract revealed a remarkable free radical scavenging activity. The treated animals exhibited a decrease in total cholesterol and triglycerides (p<0.001), insulin and leptin levels (p<0.05), visceral fat, and body weight while increasing the estradiol level at 500 mg/kg dose of the plant extract as compared with untreated animals as demonstrated from the histology of the ovary. Oxidative stress biomarkers such as superoxide dismutase, nitric oxide, malondialdehyde and reduced glutathione were significantly (p<0.01-0.001) ameliorated in treated rats. CONCLUSION: B. aristata exhibited substantial potential against obesity-inducedreproductive damage in female rats by reducing oxidative stress and resistance to leptin and insulin.


Asunto(s)
Berberis , Resistencia a la Insulina , Femenino , Ratas , Animales , Insulina/metabolismo , Ratas Wistar , Leptina , Dieta Alta en Grasa , Berberis/química , Berberis/metabolismo , Extractos Vegetales/farmacología , Obesidad/tratamiento farmacológico , Estrés Oxidativo
3.
Artículo en Inglés | MEDLINE | ID: mdl-33563161

RESUMEN

BACKGROUND & OBJECTIVE: Peganum harmala has been traditionally used to manage rheumatoid arthritis (RA) and other inflammatory conditions. However, its use against RA has not been scientifically evaluated. The current study was designed to assess the anti-arthritic and anti-inflammatory activities of the methanolic extract of P. harmala leaves by in vitro and in vivo methods. METHODS: The in vitro assays were carried out to determine the effect of plant extract on inhibition of egg albumin denaturation and human red blood cell membrane (HRBC) stabilization. Moreover, 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity was performed to determine the antioxidant potential. In vivo anti-arthritic activity was performed by determining the curative effect against Complete Freund's adjuvant (0.1 ml). The plant extract was administered to rats orally at 200, 400 and 600 mg/kg/day for 21 days. RESULTS: The values of IC50 of plant extract in protein denaturation, stabilization of HRBC and DPPH assays were 77.54 mg/ml, 23.90 mg/ml and 58.09 µg/ml, respectively. Moreover, the plant extract significantly attenuated the poly-arthritis and weight loss, anemia and paw edema. The plant extract restored the level of C-reactive protein, rheumatoid factor, alanine transaminase, aspartate transaminase and alkaline phosphatase in poly-arthritic rats. Moreover, the plant extract restored the immune organs' weight in treated rats. Treatment with P. harmala also significantly subdued the oxidative stress by reinstating superoxide dismutase, reduced glutathione, catalase and malondialdehyde in poly-arthritic rats. The plant extract notably restored the prostaglandin-E2 and tumor necrosis factor (TNF)-α in the serum of poly-arthritic rats. CONCLUSION: It was concluded that P. harmala extract had potential antioxidant, anti-inflammatory and antiarthritic activities, which primarily might be attributed to alkaloids, flavonoids and phenols.


Asunto(s)
Artritis Experimental/tratamiento farmacológico , Peganum/química , Extractos Vegetales/uso terapéutico , Animales , Antiinflamatorios/uso terapéutico , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Artritis Experimental/patología , Células Cultivadas , Membrana Eritrocítica/efectos de los fármacos , Membrana Eritrocítica/metabolismo , Adyuvante de Freund/farmacología , Adyuvante de Freund/uso terapéutico , Humanos , Medicina Tradicional , Fitoterapia , Plantas Medicinales/química , Ratas
4.
Artículo en Inglés | MEDLINE | ID: mdl-32955006

RESUMEN

BACKGROUND: Tylophora hirsuta (Wall) has long been used as traditional medicine for the treatment of diabetes. The current study is designed to evaluate the anti-diabetic and anti-inflammatory activity of different extracts of aerial parts of Tylophora hirsuta. METHODS: Sequential maceration was conducted to obtain extracts. Total phenolic contents were determined by the Folin-Ciocalteau method. The anti-oxidant activity was assessed by DPPH free radical scavenging assay. The extracts were tested for its inhibitory activity against α-amylase in-vitro. In-vivo anti-diabetic assay was conducted using alloxan-induced diabetic model and OGTT was conducted on normal rats. ELISA was used to determine the pro-inflammatory cytokines (TNF-α and IL-6). The polyphenolic composition of the extract was analyzed using an HPLC system. RESULTS: Aqueous extract exhibited highest total phenolic contents (985.24± 3.82 mg GAE/100 g DW), antioxidant activity (IC50 = 786.70 ± 5.23 µg/mL), and alpha-amylase inhibition (IC50 =352.8 µg/mL). The aqueous extract of Tylophora hirsuta showed remarkable in-vivo anti-diabetic activity. Results were compared with standard drug glibenclamide. Alloxan induced diabetic mediated alterations in liver function enzymes, renal function determinants, and lipid parameters were significantly restored in aqueous extract treated diabetic rats. A significant reduction in pro-inflammatory cytokines (p<0.001) was observed when compared to the control group. HPLC analysis confirms the presence of quercetin, gallic acid, cinnamic acid, and p-coumaric acid. CONCLUSION: These results showed that Tylophora hirsuta possesses strong anti-diabetic and anti-inflammatory potentials and justify its folklore use for the management of diabetes.


Asunto(s)
Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Depuradores de Radicales Libres/uso terapéutico , Hipoglucemiantes/uso terapéutico , Extractos Vegetales/uso terapéutico , Tylophora , Aloxano , Animales , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Diabetes Mellitus Experimental/inducido químicamente , Relación Dosis-Respuesta a Droga , Femenino , Depuradores de Radicales Libres/aislamiento & purificación , Depuradores de Radicales Libres/farmacología , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/farmacología , Masculino , Componentes Aéreos de las Plantas , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
5.
Curr Pharm Biotechnol ; 22(8): 1114-1121, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32957881

RESUMEN

BACKGROUND: Fruit peels are considered as waste and contribute to a major proportion of the biomass. They can be a good source of various therapeutic benefits. Peels biomass of citrus fruits is usually considered as garbage. Such peels may have many important and valuable medicinal components with pharmacological activities. Citrus reticulata, (Rutaceae family, local name tangerine) is a local seasonal fruit in Pakistan, a very good example of wastage of its peels. OBJECTIVE: The study is based on the exploration of a citrus fruit peel derived essential oil, its chemical characterization, identification of various bioactive components and the exploration of pharmacological potentials (antibacterial and wound healing activity). METHODS: Essential oil was recovered by hydro-distillation of freshly collected peels. Chemical constituents of oil were determined by Gas Chromatography-Mass Spectroscopy (GC-MS) analysis. Antioxidant activities were evaluated by total phenolic contents, total flavonoid content, DPPH scavenging activity and reducing power assay. Antibacterial activity was determined using disc diffusion assay. In vivo wound healing potential was determined in rabbits after topical administration of oil. Wound scoring was calculated followed by histological study. RESULTS: GC-MS analysis showed the presence of various components with the greatest proportion of D-Limonene (89.31%). Total flavonoid and phenolic contents were found to be 14.63 ± 0.95 mg CE/g and 17.03 ± 3.24 mg GAE/g respectively, while DPPH activity was found to be 73.32%. A better antibacterial activity was shown against E. coli. In vivo studies showed significant reduction in wound diameter in essential oil treatment groups. Further, the essential oil was found non-irritant in draize scoring. CONCLUSION: The study concluded that essential oil of this fruit peel might be used for antibacterial and wound healing purposes.


Asunto(s)
Antioxidantes/farmacología , Aceites Volátiles/farmacología , Extractos Vegetales/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Antibacterianos/farmacología , Citrus/química , Escherichia coli/efectos de los fármacos , Flavonoides/farmacología , Frutas/química , Cromatografía de Gases y Espectrometría de Masas , Fenoles/análisis , Conejos
6.
Pak J Pharm Sci ; 32(3 (Supplementary)): 1167-1173, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-31303586

RESUMEN

Medicinal plants are playing an imperative role in the therapy for treating various chronic ailments including arthritis. The present study was focused on finding in-vitro and in-vivo anti-arthritic potential of P. braunii roots. In vitro protein denaturation, membrane stabilization and anti-trypsinase assays were carried out to demonstrate anti-arthritic activity of the extracts. Furthermore, the extracts exerting promising in vitro anti-arthritic potential were tested orally at 150, 300 and 600mg/kg/day against formaldehyde induced arthritis in Wistar rats. The methanolic, aqueous and ethyl acetate extracts of the plant revealed noteworthy in vitro anti-arthritic activities while mitigating formaldehyde induced paw edema in dose dependent manner. Methanolic and aqueous extracts showed the highest inhibition (p<0.05) of paw edema, arthritic indices, reduced elevated level of platelets and leukocytes while increasing hemoglobin and body weight of arthritic rats. Anti-arthritic activity of the plant extracts may be due to inhibition of protein denaturation and lysosomal membrane stabilization. The plant exhibited good anti-arthritic potential.


Asunto(s)
Artritis Experimental/tratamiento farmacológico , Extractos Vegetales/farmacología , Plantas Medicinales/química , Polystichum/química , Albúminas/química , Albúminas/efectos de los fármacos , Animales , Artritis Experimental/inducido químicamente , Evaluación Preclínica de Medicamentos , Membrana Eritrocítica/efectos de los fármacos , Femenino , Formaldehído/toxicidad , Humanos , Masculino , Medicina Tradicional de Asia Oriental , Pakistán , Extractos Vegetales/química , Raíces de Plantas/química , Desnaturalización Proteica/efectos de los fármacos , Ratas Wistar , Albúmina Sérica Bovina/efectos de los fármacos
7.
Pak J Pharm Sci ; 31(6 (Supplementary): 2635-2638, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30587472

RESUMEN

Free radicals are partially reduced form of metabolites of Nitrogen and Oxygen. These are highly reactive and potentially toxic compounds which are contributing factors in different chronic disease. The present study was aimed to determine antioxidant capability and reducing ability of coded polyherbal capsules (Arthitec 1 & Arthitec 2). DPPH (2,2'-diphenyl-1-picryl hydrazyl) assay is most commonly used method for gauging antioxidant capability of natural compounds. In this assay DPPH act as stable free radical which react with an antioxidant. For measuring reducing ability suspected antioxidant react with ferric tripyridyltriazine (Fe3± TPTZ) complex and convert ferric into ferrous. Results are evident that both capsule formulations Arthitec 1 & Arthitec 2 have promising antioxidant activity and reducing potential. Antioxidant potential of both coded capsules with varied concentrations (10, 50 and 100 µg/ml) were compared and in both cases scavenging activity and as well as reducing ability raised in a dose dependent manner just like standard Butylated hydroxyanisole (BHA).


Asunto(s)
Antioxidantes/aislamiento & purificación , Antioxidantes/farmacología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Antioxidantes/metabolismo , Cápsulas , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Depuradores de Radicales Libres/aislamiento & purificación , Depuradores de Radicales Libres/metabolismo , Depuradores de Radicales Libres/farmacología , Radicales Libres/antagonistas & inhibidores , Radicales Libres/metabolismo , Extractos Vegetales/metabolismo , Preparaciones de Plantas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA